Tag: Type I Diabetes




Providers, regulators explore type 2 therapies for type 1 diabetes

Providers, regulators explore type 2 therapies for type 1 diabetes

For most children and adults with type 1 diabetes, day-to-day disease management remains difficult despite improvements in insulin formulations and delivery and advancements in diabetes technologies during the past decade.Only 17% of children and 21% of adults with type 1 diabetes meet HbA1c targets outlined in American Diabetes Association guidelines.

Source: Providers, regulators explore type 2 therapies for type 1 diabetes


Is insulin pump therapy superior to multiple daily injections in type 1 diabetes?

Is insulin pump therapy superior to multiple daily injections in type 1 diabetes?

Endocrine Today | PoinTAll pumps on the market offer several useful features for people with type 1 diabetes. These include multiple basal rate options, square- and dual-wave bolus features, the ability to calculate a suggested bolus dose based on insulin to carb ratio, insulin-on-board features to avoid insulin “stacking,” occlusion and reservoir alarms, and data downloading capabilities.

Source: Is insulin pump therapy superior to multiple daily injections in type 1 diabetes?




CGM, machine learning reveal dysglycemia phenotypes in type 1 diabetes

CGM, machine learning reveal dysglycemia phenotypes in type 1 diabetes

Researchers have identified three distinct patterns of dysglycemia in adolescents with type 1 diabetes using a combination of blinded continuous glucose monitoring data and machine-learning techniques, offering clinicians an opportunity to better tailor therapy, according to findings published in Pediatric Diabetes. “The study demonstrates that among adolescents with type 1 diabetes and

Source: CGM, machine learning reveal dysglycemia phenotypes in type 1 diabetes


‘Suspend-before-low’ feature reduces hypoglycemia with pump therapy in type 1 diabetes

‘Suspend-before-low’ feature reduces hypoglycemia with pump therapy in type 1 diabetes

Adults with long-standing type 1 diabetes and hypoglycemia unawareness using an insulin pump therapy system with an algorithm-driven, insulin-suspension feature experienced fewer hypoglycemic events than those using sensor-augmented pump therapy, according to findings published in The Lancet Diabetes & Endocrinology.

Source: ‘Suspend-before-low’ feature reduces hypoglycemia with pump therapy in type 1 diabetes